|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.290 USD | -0.77% |
|
+8.40% | -63.46% |
| 06-30 | ADC Therapeutics SA Completes Enrollment In LOTIS-7 Phase 1b ZYNLONTA Combination Trial | CI |
| 06-30 | ADC Therapeutics Completes Enrollment in LOTIS-7 Lymphoma Study | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.77% | +8.40% | +22.86% | -65.51% | -63.46% | -59.05% | -14.57% | -94.65% | - | 164M | |
| +1.84% | -0.66% | +23.66% | +15.96% | +36.03% | +59.82% | +94.48% | -23.27% | - | 54.88B | |
| +0.45% | -5.61% | +0.81% | +13.35% | +7.06% | +57.45% | +130.66% | +194.14% | +5,592.88% | 54.63B | |
| -2.24% | +3.59% | +18.15% | -25.32% | -33.57% | +17.75% | +469.23% | +309.24% | +930.39% | 25.06B | |
| -1.60% | -6.21% | +1.05% | -4.20% | -3.90% | -18.96% | -16.06% | -57.58% | - | 23.14B | |
| -1.53% | -0.90% | +21.15% | +6.18% | +19.15% | +40.04% | -7.96% | -71.47% | - | 19.87B | |
| +0.33% | +2.87% | +17.94% | +4.71% | -7.25% | +37.03% | -27.33% | -31.56% | +58.92% | 17.55B | |
| -6.84% | +2.18% | +50.20% | +120.65% | +203.28% | +195.12% | +364.56% | +1,625.01% | +698.91% | 16.5B | |
| -1.84% | -3.15% | +20.94% | +4.06% | +29.27% | +47.90% | +640.15% | - | - | 15.75B | |
| -1.05% | +1.16% | +6.34% | +27.63% | +28.91% | +25.95% | +191.69% | +213.54% | +594.53% | 14.2B | |
| -4.16% | +1.63% | +11.63% | +3.29% | -7.84% | +70.13% | +143.42% | +411.05% | - | 12.37B | |
| -1.49% | -1.10% | +8.85% | -22.47% | -12.81% | -39.00% | +622.75% | +105.25% | +103.60% | 11.84B | |
| -1.39% | -1.87% | +20.98% | +30.55% | +33.57% | +129.32% | +140.49% | +340.88% | +756.41% | 11.52B | |
| -2.01% | -6.23% | +6.94% | -30.66% | -15.44% | -19.16% | +153.11% | +57.28% | - | 11.43B | |
| -9.05% | -9.04% | +2.52% | +17.29% | +15.08% | +317.26% | +125.24% | +16.14% | +1,205.98% | 10.76B | |
| +0.06% | +0.14% | +0.53% | +20.60% | +23.17% | +53.10% | +192.56% | - | - | 9.83B | |
| -2.20% | -6.37% | +14.00% | -25.16% | +14.24% | +28.62% | +86.09% | -21.52% | - | 9.22B | |
| -0.05% | +97.92% | +142.47% | +111.92% | +79.55% | +161.76% | +318.53% | +303.38% | - | 8.81B | |
| -7.33% | -12.92% | +15.77% | +12.91% | +315.15% | +192.53% | +212.55% | -35.07% | - | 8.61B | |
| -1.02% | +12.82% | +20.98% | +90.56% | +198.35% | +522.94% | +610.84% | -44.94% | -6.91% | 8.59B | |
| Average | -2.06% | +4.21% | +21.39% | +15.32% | +42.93% | +91.03% | +221.52% | +177.55% | +1,103.86% | 17.24B | |
| Weighted average by Cap. | -1.27% | +0.89% | +17.73% | +15.45% | +33.37% | +74.44% | +198.20% | +176.98% | +2,184.06% |
- Stock Market
- Stocks
- ADCT Stock
- Sector ADC Therapeutics SA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
